PHARMA SECTOR

Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Report 2018: By Product, Application, Manufacturer, Sales and Segmentation

Press Release   •   Jan 19, 2018 05:35 EST

The recently published report titled Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry 2018 Market Research Report is an in depth study providing complete analysis of the industry for the period 2018 – 2025. It provides complete overview of Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market considering all the major industry trends, market dynamics and competitive scenario.

The Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Report 2018 is an in depth study analyzing the current state of the Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market also discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/345152

Reasons to Buy this Report

The research report will enrich your decision-making capability by helping you to –

  • Design and improve your product development and sales strategies and enhancing your marketing activities
  • Develop business strategies by understanding the market dynamics and developments driving the Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market
  • Develop market-entry strategies and effective ways to sustain competition
  • Create merger and acquisition opportunities by identifying the market players with the most innovative pipelines
  • Identify the regional market potential which would further help in designing regional market strategies
  • Understand the competitive scenario in the Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market
  • Take more informed business decisions by relying on the insightful opinions from industry experts

Why Global QY Research ?

  • Technically acclaimed Analysts with complete industry knowhow
  • Robust research methodology followed by our publishers to arrive at market estimates
  • Focus on technology trends
  • Extensive repository of market research reports to meet our client’s needs
  • Based on extensive research, we provide clear view of real market scenario and help clients with making informed business decisions


Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2025

1 Industry Overview of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx)
1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Overview
1.1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by Type
1.3.1 PCR
1.3.2 In-situ Hybridization
1.3.3 Immunohistochemistry
1.3.4 Sequencing
1.3.5 Others
1.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by End Users/Application
1.4.1 Oncology
1.4.2 Neurological Disorders
1.4.3 Cardiovascular Disease
1.4.4 Immunological Disorders
1.4.5 Others

2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Competition Analysis by Players
2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Qiagen NV
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 GE Healthcare
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 Agilent Technologies
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 F Hoffman La Roche
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Foundation Medicine
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 Thermo Fisher Scientific Inc.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Leica Biosystems Nussloch GmBH
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Pfizer
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments

4 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type and Application (2013-2018)
4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2013-2018)
4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
4.3 Potential Application of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) in Future
4.4 Top Consumer/End Users of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx)

5 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
5.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
5.2 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
5.3 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

6 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
6.1 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
6.2 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
6.3 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

7 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
7.1 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
7.2 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
7.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

8 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
8.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
8.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
8.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

9 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
9.1 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
9.2 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
9.3 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

10 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
10.1 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
10.2 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Value) by Regions (2018-2025)
11.1.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
11.1.2 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
11.1.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
11.1.4 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
11.1.5 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
11.1.6 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
11.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Value) by Type (2018-2025)
11.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2018-2025)

12 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Dynamics
12.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Opportunities
12.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/345152

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3239 2407